Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» patent cliffs
patent cliffs
With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
Fierce Pharma
Wed, 12/11/24 - 11:40 am
Gilead Sciences
Biktarvy
patent cliffs
HIV
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
Fierce Pharma
Wed, 11/13/24 - 09:49 pm
M&A
Bristol Myers Squibb
Amgen
patent cliffs
How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs
BioSpace
Wed, 06/26/24 - 09:54 am
patents
Pfizer
Bristol Myers Squibb
JNJ
patent cliffs
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's
Fierce Pharma
Tue, 06/21/22 - 11:56 pm
Pfizer
Merck
Bristol Myers Squibb
patents
patent cliffs
M&A
JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid's patent cliff
Fierce Pharma
Mon, 01/10/22 - 11:49 pm
JPMHC 2022
Bristol Myers Squibb
Revlimid
patent cliffs
Opdivo
Eliquis
Reblozyl
Breyanzi
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Fierce Pharma
Fri, 12/31/21 - 11:10 am
patents
patent cliffs
Bristol Myers Squibb
Amgen
Pfizer
Revlimid
Eliquis
Enbrel
Otezla
Ibrance
Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space
TheStreet.com
Tue, 06/13/17 - 05:48 pm
drug pricing
patents
patent cliffs
M&A
generics
Pharma Starts a Feedback Loop
Drug Patent Watch
Mon, 06/12/17 - 10:08 am
patents
generics
patent expirations
patent cliffs
innovation
drug development